Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Vice President | November 13, 2020 | November 16, 2020 |
| STEPAN COSCL · Entity 4733 | Vice President, Supply Chain | March 03, 2017 | March 07, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date November 13, 2020 · Filed November 16, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,675 |
Reported balance
After 2020-11-13 transaction · row 1
1 source rowRow 1 · 2020-11-13 · Sale · Disposed 3,000 · Balance 9,675 |
STEPAN CO
Report date March 03, 2017 · Filed March 07, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,061 |
Reported balance
After 2017-03-03 transaction · row 1
1 source rowRow 1 · 2017-03-03 · Tax withholding · Disposed 580 · Balance 17,061 F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 21, 2017, which were reported on the Form 4 filed for the reporting person on February 23, 2017. Withholding of these shares were applied to the reporting person's account on the transaction date shown. |
| Common StockSEC Table I · non-derivative | IndirectBy Esop II Trust | 994.63 |
Reported balance
Holding disclosure · report date 2017-03-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 994.63 |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 21, 2017, which were reported on the Form 4 filed for the reporting person on February 23, 2017. Withholding of these shares were applied to the reporting person's account on the transaction date shown.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2020 Filed Nov 16, 2020 14:29 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 3,000 | $103.00 | $309,000.00 |
DisclosureSEC source: 0001140361-20-025595 · form4.xml · nonDerivative · entry 1 MASON SCOTT C · CIK 0001120330 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,675 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 15:42 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 4,300 | $0.00 Strike: $111.94 | $0.00 |
DisclosureSEC source: 0001140361-20-003480 · form4.xml · derivative · entry 2 MASON SCOTT C · CIK 0001120330 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 4,300 shares Expires 2030-02-13 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 15:42 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003480 · form4.xml · nonDerivative · entry 1 MASON SCOTT C · CIK 0001120330 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,522 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| August 05, 2019 Filed Aug 5, 2019 21:51 UTC | BALCHEM CORP BCPC · Entity 3839 | PurchaseCommon Stock | 3,000 | $84.74 | $254,220.00 |
DisclosureSEC source: 0001140361-19-014255 · form4.xml · nonDerivative · entry 1 MASON SCOTT C · CIK 0001120330 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,524 Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 23:55 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 580 | $78.52 | $45,541.60 |
DisclosureSEC source: 0001127602-17-010716 · form4.xml · nonDerivative · entry 1 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,061 F1 · kind: The transaction reported reflects the withholding of shares from the performance shares vested on February 21, 2017, which were reported on the Form 4 filed for the reporting person on February 23, 2017. Withholding of these shares were applied to the reporting person's account on the transaction date shown. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 01:58 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 102.495 | $78.91 | $8,087.88 |
DisclosureSEC source: 0001127602-17-008087 · form4.xml · nonDerivative · entry 2 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 994.63 Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:58 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 1,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-008087 · form4.xml · derivative · entry 6 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F4 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F4 · derivative.exercise_date: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F4 · derivative.expiration_date: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:58 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008087 · form4.xml · derivative · entry 5 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,291 Underlying: Common Stock · 2,291 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:58 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 8,544 | $0.00 Strike: $78.58 | $0.00 |
DisclosureSEC source: 0001127602-17-008087 · form4.xml · derivative · entry 4 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544 Underlying: Common Stock · 8,544 shares Expires 2027-02-20 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:58 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Option (Right to Buy) · Derivative | 2,848 | $0.00 Strike: $78.58 | $0.00 |
DisclosureSEC source: 0001127602-17-008087 · form4.xml · derivative · entry 3 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,848 Underlying: Common Stock · 2,848 shares Expires 2027-02-20 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:58 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-008087 · form4.xml · nonDerivative · entry 1 MASON SCOTT C · CIK 0001120330 · Vice President, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Amount reported reflects vesting of 1,738 performance shares as shown on Table II due to achievement of certain financial targets by December 31, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.